Cellular Biomedicine Group Inc (NASDAQ:CBMG)

17.10
Delayed Data
As of May 25
 -0.40 / -2.29%
Today’s Change
5.50
Today|||52-Week Range
22.75
+52.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues564.4K2.5M627.9K336.8K
 
 
 
 
 
Cost of Goods Sold213.2K833.0K860.4K162.2K
 
 
 
 
 
Depreciation And Amortization1.2M2.1M2.6M3.0M
 
 
 
 
 
 
Operating ExpensesGross Income-839.4K-422.2K-2.9M-2.8M
 
 
 
 
 
General Expenses10.2M20.3M20.9M24.8M
 
 
 
 
 
Research And Development2.7M7.6M11.5M14.6M
 
 
 
 
 
Total Operating Expenses11.6M23.2M24.4M27.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.0M-20.7M-23.8M-27.6M
 
 
 
 
 
Extraordinary Charge-1.4M-123.4K-4.6M0.00
 
 
 
 
Other Expenses72.0K630.4K54.1K-122.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.4M-20.2M-28.2M-25.5M
 
 
 
 
 
Income Taxes0.00-728.6K-4.1K-2.5K
 
 
 
 
Discontinued Operations-3.1M0.000.000.00
 
 
Net Income-15.5M-19.4M-28.2M-25.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.6M11.5M13.5M14.3M
 
 
 
 
 
Shares To Calculate EPS Diluted8.6M11.5M13.5M14.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.79-$1.70-$2.09-$1.78
 
 
 
 
 
EPS Diluted-$1.79-$1.70-$2.09-$1.78